HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Puoti Selected Research

Coinfection

6/2022Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study).
1/2019Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C.
5/2018Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study.
2/2018Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP).
1/2018HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.
1/2017Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.
1/2017Use of Daclatasvir in HCV/HIV-Coinfected Patients in a Real-Life Setting.
10/2015An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project.
8/2015Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
7/2015Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Puoti Research Topics

Disease

47Infections
01/2022 - 01/2002
34Coinfection
06/2022 - 01/2002
25Fibrosis (Cirrhosis)
01/2022 - 08/2002
16Chronic Hepatitis C
01/2022 - 08/2002
15COVID-19
06/2022 - 08/2020
15Liver Diseases (Liver Disease)
01/2022 - 07/2005
14Hepatitis C
12/2019 - 07/2002
11Hepatitis
01/2022 - 08/2002
9Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2004
8HIV Infections (HIV Infection)
05/2020 - 01/2008
6Pneumonia (Pneumonitis)
11/2021 - 02/2018
6Hepatitis B
10/2017 - 01/2002
3End Stage Liver Disease
05/2022 - 07/2002
3Acquired Immunodeficiency Syndrome (AIDS)
01/2021 - 01/2011
3Disease Progression
01/2006 - 07/2002
2Hepatocellular Carcinoma (Hepatoma)
05/2022 - 04/2011
2Vasculitis (Vasculitides)
01/2022 - 06/2011
2Diabetes Mellitus
12/2021 - 01/2016
2Cardiovascular Diseases (Cardiovascular Disease)
07/2021 - 09/2015
2Viremia
02/2021 - 06/2005
2Bacterial Infections (Bacterial Infection)
11/2020 - 12/2014
2Rheumatoid Arthritis
11/2019 - 01/2016
2Neoplasms (Cancer)
10/2018 - 01/2018
2Virus Diseases (Viral Diseases)
01/2018 - 01/2017
2Persistent Infection
10/2015 - 11/2002
2Insulin Resistance
07/2015 - 04/2008
2Communicable Diseases (Infectious Diseases)
05/2014 - 08/2012
2Chronic Hepatitis B
02/2006 - 01/2006
1Superinfection
06/2022
1Clinical Deterioration
01/2022
1Breakthrough Infections
12/2021
1Respiratory Insufficiency (Respiratory Failure)
11/2021
1Multiple Sclerosis
01/2021
1Critical Illness (Critically Ill)
01/2021
1Invasive Fungal Infections
12/2020
1Heart Failure
11/2020

Drug/Important Bio-Agent (IBA)

23Antiviral Agents (Antivirals)IBA
01/2022 - 08/2004
23Ribavirin (Virazole)FDA LinkGeneric
11/2018 - 08/2002
16InterferonsIBA
01/2018 - 01/2002
15Pharmaceutical PreparationsIBA
07/2021 - 10/2004
14RNA (Ribonucleic Acid)IBA
12/2021 - 01/2008
7SofosbuvirIBA
12/2019 - 05/2014
6glecaprevir and pibrentasvirIBA
05/2021 - 01/2018
6Ritonavir (Norvir)FDA Link
10/2020 - 07/2014
4tocilizumab (atlizumab)FDA Link
01/2021 - 08/2020
4Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2021 - 06/2009
4ombitasvirIBA
11/2018 - 01/2017
4dasabuvirIBA
11/2018 - 01/2017
4paritaprevirIBA
11/2018 - 01/2017
4EnzymesIBA
07/2014 - 07/2005
3daclatasvirIBA
01/2019 - 01/2017
3Alanine Transaminase (SGPT)IBA
01/2019 - 02/2006
3Transaminases (Aminotransferases)IBA
05/2016 - 01/2007
3DNA (Deoxyribonucleic Acid)IBA
01/2016 - 04/2011
3N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
09/2015 - 09/2013
3telaprevirIBA
09/2015 - 09/2013
3LipidsIBA
01/2006 - 03/2002
2Immunoglobulin G (IgG)IBA
12/2021 - 01/2017
2Oxygen (Dioxygen)IBA
11/2021 - 01/2021
2AntigensIBA
01/2021 - 01/2021
2VaccinesIBA
01/2021 - 05/2014
2Anti-Bacterial Agents (Antibiotics)IBA
11/2020 - 02/2018
2Biological ProductsIBA
11/2019 - 10/2017
2Immunosuppressive Agents (Immunosuppressants)IBA
10/2018 - 05/2014
2pibrentasvirIBA
01/2018 - 01/2018
2glecaprevirIBA
01/2018 - 01/2018
2sofosbuvir drug combination ledipasvirIBA
12/2016 - 05/2014
2Triglycerides (Triacylglycerol)IBA
01/2016 - 11/2002
2Anti-Retroviral Agents (Antiretroviral Agents)IBA
10/2015 - 07/2015
2lipoarabinomannan (LAM)IBA
04/2013 - 06/2009
2Lamivudine (Epivir)FDA Link
06/2009 - 01/2006
1Carbapenems (Carbapenem Antibiotics)IBA
06/2022
1Rheumatoid FactorIBA
01/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022
1Atazanavir Sulfate (Reyataz)FDA Link
12/2021
1BNT162 VaccineIBA
12/2021
1ElectrolytesIBA
12/2021
1PotassiumIBA
12/2021
1ChlorineIBA
12/2021
1CalciumIBA
12/2021
1SodiumIBA
12/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1carbapenemaseIBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1defibrotideIBA
01/2021
1GlucansIBA
12/2020
1dalbavancinIBA
12/2020

Therapy/Procedure

41Therapeutics
01/2022 - 01/2002
11Highly Active Antiretroviral Therapy (HAART)
01/2015 - 01/2002
8Liver Transplantation
05/2022 - 07/2002
5Kidney Transplantation
10/2020 - 10/2018
4Duration of Therapy
12/2019 - 11/2013
4Renal Dialysis (Hemodialysis)
02/2019 - 10/2018
3Opiate Substitution Treatment
10/2020 - 12/2016
2Length of Stay
11/2020 - 02/2018
2Drug Tapering
05/2016 - 01/2015
1Artificial Respiration (Mechanical Ventilation)
01/2021
1Aftercare (After-Treatment)
01/2021
1Plasma Exchange
01/2021